• Home
  • Search
  • Machine learning-based MRI imaging for prostate cancer diagnosis: systematic review and meta-analysis.
  • Cite Icon8
  • https://doi.org/10.1038/s41391-025-00997-2Copy DOI Icon

Machine learning-based MRI imaging for prostate cancer diagnosis: systematic review and meta-analysis.

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

This study aims to evaluate the diagnostic value of machine learning-based MRI imaging in differentiating benign and malignant prostate cancer and detecting clinically significant prostate cancer (csPCa, defined as Gleason score ≥7) using systematic review and meta-analysis methods. Electronic databases (PubMed, Web of Science, Cochrane Library, and Embase) were systematically searched for predictive studies using machine learning-based MRI imaging for prostate cancer diagnosis. Sensitivity, specificity, and area under the curve (AUC) were used to assess the diagnostic accuracy of machine learning-based MRI imaging for both benign/malignant prostate cancer and csPCa. A total of 12 studies met the inclusion criteria, with 3474 patients included in the meta-analysis. Machine learning-based MRI imaging demonstrated good diagnostic value for both benign/malignant prostate cancer and csPCa. The pooled sensitivity and specificity for diagnosing benign/malignant prostate cancer were 0.92 (95% CI: 0.83-0.97) and 0.90 (95% CI: 0.68-0.97), respectively, with a combined AUC of 0.96 (95% CI: 0.94-0.98). For csPCa diagnosis, the pooled sensitivity and specificity were 0.83 (95% CI: 0.77-0.87) and 0.73 (95% CI: 0.65-0.81), respectively, with a combined AUC of 0.86 (95% CI: 0.83-0.89). Machine learning-based MRI imaging shows good diagnostic accuracy for both benign/malignant prostate cancer and csPCa. Further in-depth studies are needed to validate these findings.

Similar Papers
  • Research Article
  • Citations10

Use of two gene panels for prostate cancer diagnosis and patient risk stratification.

  • Jan 28, 2016
  • Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
  • Kefeng Xiao +8
  • Research Article

Combined DNA-methylation intensity and clinical risk score to stratify patients for high-grade disease.

  • Jan 10, 2016
  • Journal of Clinical Oncology
  • Leander Van Neste +9
  • Research Article
  • Citations1

Abstract 4013: A novel quantitative histomorphological tool to assess multiple biomarkers to predict prostate cancer aggression

  • Sep 30, 2014
  • Cancer Research
  • Zhi Liu +6
  • Research Article
  • Citations1

Abstract 4720: Evaluation of a genomic classifier (Decipher®) in subsets of primary tumors with common prostate cancer genomic alterations

  • Sep 30, 2014
  • Cancer Research
  • Mohammed Alshalalfa +5
  • Research Article
  • Citations265

Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection

  • Feb 13, 2010
  • European Urology
  • Flip H Jansen +9
  • Research Article
  • Citations84

NOVEL STAGING TOOL FOR LOCALIZED PROSTATE CANCER: A PILOT STUDY USING GENETIC ADAPTIVE NEURAL NETWORKS

  • Aug 01, 1998
  • Journal of Urology
  • Ashutosh Tewari +1
  • Research Article

Clinical Significance of the Expression of Tubulin α and βII in Prostate Cancer

  • Jan 01, 2008
  • Korean Journal of Urology
  • Tae Heung Kim +5
  • Research Article

Application of proton density fat fraction imaging in risk stratification of prostate cancer.

  • Sep 01, 2024
  • Translational andrology and urology
  • Guangzheng Li +6
  • Research Article
  • Citations64

Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.

  • Feb 10, 2015
  • Prostate Cancer and Prostatic Diseases
  • A D Raval +5
  • PDF
  • Research Article
  • Citations2

The diagnostic performance of 18F-DCFPyL PET in patients with suspected prostate cancer: A systemic review and meta-analysis.

  • Mar 07, 2023
  • Frontiers in Oncology
  • Wenyang Pang +3
  • Research Article
  • Citations1

Diagnostic Value of a Global Leadership Initiative on Malnutrition Criteria in Patients with Malignant Tumors: A Systematic Review and Meta-Analysis.

  • Apr 26, 2025
  • Nutrition reviews
  • Zecheng Zhang +5
  • Research Article
  • Citations51

How to use prostate-specific antigen in the early detection or screening for prostatic carcinoma.

  • May 01, 1995
  • CA: A Cancer Journal for Clinicians
  • M K Brawer
  • Research Article
  • Citations5

Addressing intra- and inter-institution variability of a radiomic framework based on Apparent Diffusion Coefficient in prostate cancer.

  • Aug 22, 2024
  • Medical physics
  • Letizia Morelli +12
  • Research Article
  • Citations5

Urinary endogenous peptides as biomarkers for prostate cancer

  • Mar 14, 2023
  • Oncology Letters
  • Cristine De Souza Dutra +13
  • Research Article
  • Citations92

Oxidative Stress Measured by Urine F2-Isoprostane Level is Associated With Prostate Cancer

  • Apr 15, 2011
  • Journal of Urology
  • Daniel A Barocas +11
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.